NEW YORK, Jan. 21, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Twist Bioscience Corporation (“Twist” or the “Company”) TWST. Those investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, extension 7980.

The investigation concerns whether Twist and certain of its officers and/or directors have engaged in securities fraud or other illegal business practices.

[Click here for information about joining the class action]

On November 15, 2022, Scorpion Capital published a summary report on Twist (the “Scorpion Report”). The Scorpion Report described Twist as “[t]The latest miniaturized ‘lab-on-a-chip’ scam, just like Theranos, Berkeley Lights and other failures” and “[a] ticking time bomb that we believe is resorting to a Worldcom-style accounting fraud”.[m]Several competitors internally refer to Twist’s price dumping and customer subsidy program as “Ponzi.”

Following the release of the Scorpion report, Twist’s stock price fell $7.57 per share, or 19.92%, to close at $30.43 per share on November 15, 2022.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris and Tel Aviv, is recognized as one of the leading law firms specializing in corporate, securities and antitrust litigation. Founded by the late Abraham L. Pomerantz, best known as Dean of the Class Bar Association, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues the tradition he founded and fights for the rights of victims of securities fraud, fiduciary breaches and corporate wrongdoing. The firm has recovered numerous multi-million dollar claims on behalf of group members. See www.pomlaw.com.

CONTACT:
Robert S Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
888-476-6529 ext. 7980